ANURAS vs FAIRCHEMOR: Stock Comparison
ANUPAM RASAYAN INDIA is the larger company by market capitalisation. ANUPAM RASAYAN INDIA shows a higher ROE, faster revenue growth and a higher ROCE, while FAIRCHEMOR shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ANURAS leads 6; FAIRCHEMOR leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ANURAS | FAIRCHEMOR |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | ANURAS | FAIRCHEMOR |
|---|---|---|
| Live Price | ₹1,219.4 | ₹728.75 |
| Day Change | -0.95% | -2.87% |
| Volume | 4.19 L | 44,227 |
| 52-Week High | ₹1,415 | ₹827.9 |
| 52-Week Low | ₹1,045.2 | ₹428.05 |
| Distance from 52W High | -13.82% | -11.98% |
Valuation
| Metric | ANURAS | FAIRCHEMOR |
|---|---|---|
| Market Cap | ₹13,882 Cr | ₹787 Cr |
| P/E Ratio | 79.44x | 55.39x |
| P/B Ratio | 4.16x | 3.02x |
| EPS | ₹2.81 | ₹7.95 |
| Book Value | ₹406.68 | ₹208.83 |
| Dividend Yield | 0% | 0.16% |
Growth
| Metric | ANURAS | FAIRCHEMOR |
|---|---|---|
| Revenue Growth (TTM YoY) | 27.5% | -3.2% |
| EPS Growth (TTM YoY) | -7.6% | 519.6% |
| Qtr Sales Growth | -49.8% | -61.68% |
| Qtr Profit Growth | -37.51% | 80.74% |
Profitability & Leverage
| Metric | ANURAS | FAIRCHEMOR |
|---|---|---|
| ROE | 4.8% | 2.11% |
| ROCE | 6.64% | 2.48% |
| Net Margin | 8.41% | 1.21% |
| Operating Margin | 17.04% | 2.4% |
| Debt to Equity | 0.39x | 0.32x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ANURAS | FAIRCHEMOR |
|---|---|---|
| Promoter Holding | 27.27% | 6.07% |
| FII Holding | 7.71%▲ 0.8 pp | 6.34%▼ 0.01 pp |
| DII Holding | 0.38%▲ 0.03 pp | 2.8%▼ 1.19 pp |
| Public Holding | 32.83%▼ 0.84 pp | 27.6%▲ 1.19 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ANUPAM RASAYAN INDIA and FAIRCHEMOR.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.